Invivyd, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $53.4M | $25.4M | $0 | — | — |
| Operating income | -$55.6M | -$176.9M | -$212.8M | -$248.0M | -$226.9M |
| Operating expenses | $109.0M | $202.3M | $212.8M | $248.0M | $226.9M |
| Cash from operations | -$58.1M | -$170.5M | -$173.2M | -$220.0M | -$184.7M |
| Capital expenditure | $155,000 | $140,000 | $615,000 | $1.7M | $84,000 |
| Free cash flow | -$58.3M | -$170.6M | -$173.8M | -$221.7M | -$184.8M |
| Share repurchases | — | $0 | $1,000 | $4,000 | $0 |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $276.9M | $129.5M | $229.2M | $383.2M | $620.1M |
| Total liabilities | $35.3M | $62.0M | $51.7M | $27.2M | $62.1M |
Shares outstanding 294.6M · Free float 87.1%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.